On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Eisai (United States)

InstitutionResearch output, impact & collaborations

Eisai (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Eisai (United States)?

ScholarIQrecord summary

Eisai (United States) is a research organisation in Woodcliff Lake, US. OpenAlex records 2,587 works and 360,952 citations for it. 490 researchers list it as their most recent affiliation.

How many works does Eisai (United States) have?

ScholarIQindexed works

Eisai (United States) has 2,587 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Eisai (United States) have?

ScholarIQcitation count

Eisai (United States) has 360,952 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Eisai (United States)?

ScholarIQresearcher count

Eisai (United States) has 490 researchers in the ScholarIQ index.

What is the average h-index at Eisai (United States)?

ScholarIQavg h-index

Eisai (United States) has an average h-index of 46 in OpenAlex.

What is the ROR of Eisai (United States)?

ScholarIQror

The ROR for Eisai (United States) is on the source record.

What is the OpenAlex record for Eisai (United States)?

ScholarIQopenalex

The OpenAlex for Eisai (United States) is on the source record.

Who are the most-cited researchers behind Eisai (United States)?

ScholarIQtop researchers by citations
1
Michael C. Irizarry · Alzheimer's disease research and treatments
242 works20,738 citations
2
Lynn D. Kramer · Alzheimer's disease research and treatments
92 works20,130 citations

What are the most-cited papers on Eisai (United States)?

ScholarIQmost cited works
Lecanemab in Early Alzheimer’s Disease
Christopher H. van Dyck, Chad J. Swanson, Paul Aisen, Randall J. Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer, Takeshi Iwatsubo
New England Journal of Medicine. 20225,416 CitationsOPEN ACCESS
Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
Robert H. Dworkin, Dennis C. Turk, Kathleen W. Wyrwich, Dorcas Beaton, Charles S. Cleeland, John T. Farrar, Jennifer A. Haythornthwaite, Mark P. Jensen, Robert D. Kerns, Deborah N. Ader, Nancy A. Brandenburg, Laurie B. Burke, David Cella, Julie Chandler, Penny Cowan, Rozalina Dimitrova, Raymond A. Dionne, Sharon Hertz, Alejandro R. Jadad, Nathaniel P. Katz, Henrik Kehlet, Lynn D. Kramer, Donald C. Manning, Cynthia G. McCormick, Michael McDermott, Henry J McQuay, Sanjay Patel, Linda Porter, Steve Quessy, Bob A. Rappaport, Christine Rauschkolb, Dennis A. Revicki, Margaret Rothman, Kenneth E. Schmader, Brett R. Stacey, Joseph Stauffer, Thorsten von Stein, Richard E. White, James Witter, Stojan Zavisic
Journal of Pain. 20073,447 Citations
Candidate Single-Nucleotide Polymorphisms From a Genomewide Association Study of Alzheimer Disease
Hao Li, Sally Wetten, Li Li, Pamela L. St. Jean, Ruchi Upmanyu, Linda Surh, David A. Hosford, Michael R. Barnes, J. D. Briley, Michael Borrie, Natalie Coletta, Richard G. Delisle, Daniella Dhalla, Margaret G. Ehm, Howard Feldman, Luis Fornazzari, Serge Gauthier, Neil Goodgame, Danilo Guzman, Sandra Noll Hammond, Paul Hollingworth, Ging‐Yuek Robin Hsiung, Joan Johnson, Devon D. Kelly, Ron Keren, Andrew Kertesz, Karen S. King, Simon Lovestone, Inge Loy-English, Paul M. Matthews, Michael J. Owen, Mary Plumpton, William Pryse‐Phillips, Rab K. Prinjha, Jill Richardson, Ann M. Saunders, Andrew J. Slater, Peter St George‐Hyslop, Sandra W. Stinnett, Jina Swartz, Rachel L. Taylor, John R. Wherrett, Julie Williams, David P. Yarnall, Rachel A. Gibson, Michael C. Irizarry, Lefkos Middleton, Allen D. Roses
Archives of Neurology. 2007509 Citations

How much of the research on Eisai (United States) is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
33%
Closed
67%

Related on ScholarIQ

470M+ articles · 14-day free trial